AMERI-FAB, LLC’s Post

Last week, the ESAB Corporation leadership team and I traveled to New York City to lay out our five-year strategic plan for ESAB 2.0 to analysts and investors. ESAB is fundamentally, a very different company than we were seven years ago, and we have transformed ourselves into a phenomenal global business, and we are well-positioned to succeed in this next phase of our legacy.   As I stated last week, ESAB 2.0 will see continued focus on creating a premier industrial compounder, with capital allocation aligned to our strategy, focus on improving margins and cash flow, and accelerated innovation and M&A driving growth. We are confident that this strategy will continue to drive sales growth, margin expansion, and free cash flow to create long-term value for each of our shareholders.   I am confident that we have the right strategy, product mix and talent in place to deliver on our goals. As was said last week, the best is yet to come.   Kevin Johnson, Olivier Biebuyck, Piyush Sheth, Mark Barbalato   #ShapingtheWorldWeImagine #ESABCorporation 

BetMGM Launches In UK Using LeoVegas 🇬🇧 BetMGM UK launch is first since acquisition of LeoVegas 💷 Entain expects no impact on UK market from BetMGM’s launch 🇺🇸 BetMGM to still operate in U.S., Canada with Entain technology Read the full blog written by Harrison Sayers here: https://bit.ly/3OMHwRT #GamblingNews #GamblingCompliance #GamblingRegulation

As I celebrate my 2nd year of growth and accomplishments, I want to extend my gratitude to each and every one of Sydea's team. Wishing us continued success, growth, and fulfillment in the years ahead! https://www.sydea.it/ Antonio De Vivo Yuri Alessandro De vivo #saperp #consulting #businessprocessmanagement #businessprocess

🚀Exciting News! 🎉 #SOCO is now equipped with new equipment to provide better and quicker service in #SuperAbsorbentPolymer. Stay tuned for more updates and exciting announcements as we embark on this journey of progress and innovation together! 🌱 #SOCO #SuperAbsorbentPolymer #FactoryExpansion #InvestmentInnovation #CreatingSuccess 

🚀Exciting News! 🎉 #SOCO is now equipped with new equipment to provide better and quicker service in #SuperAbsorbentPolymer. Stay tuned for more updates and exciting announcements as we embark on this journey of progress and innovation together! 🌱 #SOCO #SuperAbsorbentPolymer #FactoryExpansion #InvestmentInnovation #CreatingSuccess 

We are thrilled to welcome ketl to the Confidencial Partner Network Program (CPN). Together we are not just enhancing document security; we are changing the way organizations operate, making secure document management a seamless part of daily work! Learn more below! #documentmanagement #cybersecurity #encryption

IMAB IMAB Signs agreement to Divest its Assets and Business Operations in China My one mile high view of the news. IMAB will release themselves of the potential $183M Series A and Series B put right obligations. There is a potential (and likely) payment in September of $30M to non-participating shareholders. IMAB gives up the $250M potential Jumpcan money for eftansomatropin alfa. They cede the China rights to Felzartamab, Givastomig, and Uliledlimab. They get 10% of Hangzhou if the company goes public. The $80M from Hangzhou milestone events will take several years to materialize. In the short-term, IMAB will save money on China development costs. Obviously that money would be used to funds USA development of Givastomig, Uliledlimab, etc. Down the road, IMAB may sacrifice what could be $500M of potential China business (elfa, giva, uli, felza). If the drugs are successful then IMAB would benefit from the 10% stake in Hangzhou. Why take this action now? I think today's steps are taken to facilitate future actions that may appear within 2 years. I think the catalysts for the company will be the development of Givastomig and Uliledlimab that could lead to $1B in potential licensing deals.

Here are the top contributors to the #Nifty50 change. #LarsenandToubro #ICICIBank #infosis #tcs #hdfcbank #HindalcoIndustries #hcltech #sunpharma #powergrid #ntpc

Happy Friday! Indian #Pharma Firms Zoom in on #Anti-obesity Drug Development Amid Surge in #Ozempic Sales Indian pharma firms are developing anti-obesity drugs in response to the increasing demand caused by the rising prevalence of obesity and the success of #Ozempic (semaglutide). Ozempic is expected to reach $12.5 billion in sales by 2023. Pharma Majors like Dr. Reddy's, Lupin, Zydus, and Sun Pharma are actively working on #anti-obesity drugs due to the limited availability of such medications in the #Indian market. Market reports indicate that the weight management market in India is projected to reach Rs 2,762.7 crore by 2028, with a significant growth rate of 10.6%. Indian pharma companies are conducting studies and forming alliances to address the growing anti-obesity market. Continue reading on https://lnkd.in/dbQ67H5j

Unveiling Agyl & Partners: Where Clarity Meets Agility Thrilled to introduce my latest venture, Agyl & Partners, a consultancy aimed at ushering businesses through the regulatory maze to a realm where clarity sparks agility. With over 15 years in Malaysia's transport industry and regulatory spheres, I've seen firsthand how clear guidelines can fuel business innovation and growth. At Agyl & Partners, our mission extends beyond just aligning with existing regulatory frameworks even beyond transport industry. We aspire to shape them, guiding firms towards not just compliance, but excellence. Our team of seasoned experts is ready to devise strategies that translate complex policies into actionable insights, propelling businesses forward. I'm extending an open invitation to explore collaborations, share insights, or simply connect to discuss the dynamic regulatory landscape. Your thoughts and engagement are the catalysts for broader discussions that drive change. Visit our website https://agylpartners.com/ to learn more about our approach and how we can navigate the regulatory terrain together. Excited for the dialogues and partnerships that lie ahead! #AgylAndPartners #NavigatingRegulation #BusinessInnovation #Collaboration #NewVenture